Skip to main content
Premium Trial:

Request an Annual Quote

NCATS Leases Rockville Home for Pre-Clinical Studies Division

NEW YORK (GenomeWeb News) – The National Center for Advancing Translational Sciences has leased a 75,000-square-foot space at the Shady Grove Life Sciences Center in Rockville, Md., Alexandria Real Estate Equities said today.

The 15-year lease on the space in Rockville, owned by Alexandria and located near the National Institutes of Health campus, will house NCATS' Division of Pre-Clinical Innovation.

With this agreement, NIH now leases a total of 135,000 square feet in the Shady Grove center, including 60,000 square feet that serves as a home for the NIH Chemical Genomics Center.

The Division of Pre-Clinical Innovation advances collaborative research projects, and includes the Therapeutics for Rare and Neglected Diseases program, which is focused on the development of new drugs through collaborations between NIH, industry, and researchers at academic and non-profit institutes.

Terms of the lease were not disclosed.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.